XML 73 R50.htm IDEA: XBRL DOCUMENT v3.3.1.900
Disposition (Details)
CAD in Thousands, $ in Thousands
12 Months Ended
Oct. 01, 2015
CAD
Dec. 31, 2015
USD ($)
Oct. 01, 2015
USD ($)
Gain on sale of subsidiary   $ 1,016  
Zalicus Pharmaceuticals, Ltd | Discontinued Operations, Disposed of by Sale      
Proceeds from purchase agreement | CAD CAD 5,000    
Limited recourse promissory note | CAD CAD 5,000    
Gain on sale of subsidiary   $ 1,016  
Z944 | Zalicus Pharmaceuticals, Ltd | Discontinued Operations, Disposed of by Sale      
Maximum payments to be received for achievement of certain development and regulatory approval milestones     $ 7,500
Maximum payments to be received for achievement of certain sales milestones     $ 30,000